Selumetinib side effects in children treated for plexiform neurofibromas: first case reports of peripheral edema and hair color change.

Since the use of selumetinib to treat plexiform neurofibromas is increasing in the pediatric population, clinicians should be aware of its side effects, so to decide whether continuing the treatment, reducing the dose or even interrupting it, when appropriate.